AM-0902

AM-0902

收藏
  • ¥915
  • 爱必信(Absin)
  • 中国
  • abs821333
  • 2025年07月12日
    avatar
  • 企业认证

    • 详细信息
    • 技术资料
    • 库存

      99

    • 供应商

      爱必信(上海)生物科技有限公司

    • 规格

      10mg

    公告提醒:爱必信所有产品和服务仅用于科学研究不用于临床应用及其他用途提供产品和服务也不为任何个人提供产品和服务)!

     

    抑制剂描述:

    产品名称:AM-0902

    产品别名:见爱必信官网

    英文别名:AM-0902

    靶点:TRP Channel

    CAS:1883711-97-4

    纯度:98%

    外观:见爱必信官网

    保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.

    描述:AM-0902 is a potent, selective transient receptor potential A1 (TRPA1) antagonist with IC50s of 71 and 131 nM for rTRPA1 and hTRPA1, respectively.

    溶解性:DMSO : 150 mg/mL (404.54 mM; Need ultrasonic and warming)

    体外研究:

    AM-0902 is a potent, selective antagonist of TRPA1 with IC50s of 71 and 131 nM for rTRPA1 and hTRPA1, respectively. AM-0902 is highly permeable (average Papp=44.5 μcm/s in MDCK cells), an unlikely substrate for P-gp (efflux ratio=1.3 in P-gp overexpressing MDCK cells), and demonstrates good solubility (PBS pH 7.4: 226 μM, SIF: 248 μM). AM-0902 shows good selectivity over other TRP channels, as no activity is observed against human TRPV1 or TRPV4, or rat TRPV1, TRPV3, or TRPM8, at concentrations up to 10 μM. AM-0902 inhibits 45Ca2+ flux upon activation of rat TRPA1 with methylglyoxal with an IC50 of 0.019 μM.

    体内研究:AM-0902 is a potent, selective antagonist of TRPA1 in vivo. AM-0902 has moderate terminal elimination half-life (t1/2=0.6 h and 2.8 h for rat (0.5 mg/kg, iv), rat (30 mg/kg, oral)). A dose-dependent reduction of allyl isothiocyanate (AITC)-induced flinching is observed for AM-0902, with a significant reduction in flinching observed postdosing of 10 and 30 mg/kg. The unbound plasma concentrations (Cu) at 1 h for the 1, 3, 10, and 30 mg/kg doses are 0.051±0.024 (n=8), 0.19±0.11 (n=8), 0.58±0.35 (n=8), and 2.2±0.40 (n=8) μM, covering the in vitro rat TRPA1 45Ca2+ IC50 at 0.72, 2.7, 8.2, and 30.3 fold, respectively. A good exposure-response relationship is observed in this target coverage model. An unbound in vivo IC50 of 0.35 μM, which is in good agreement with the in vitro rat TRPA1 45Ca2+ IC50, and unbound in vivo IC90 of 1.7 μM are determined. It is noteworthy that at a dose of 30 mg/kg, AM-0902 engages TRPA1 at concentrations that exceed the in vivo IC90, making it a useful tool for exploration of in vivo models of acute pain.

    产品信息订购:

      产品货号   产品名称   规格 价格 大包装及货期
      abs821333   AM-0902   10mg   1150.00   立即咨询
      abs821333   AM-0902   50mg   3550.00   立即咨询

    产品更多信息请进入爱必信(absin)商城查看》》》



    absin,您身边的科研百宝箱
    专业提供试剂、耗材、仪器,在线订购,7*24h全国发货,方便快捷!

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1
    博奥派克生物
    2025年07月08日询价
    ¥14960
    爱必信(上海)生物科技有限公司
    2025年07月12日询价
    ¥620
    广州市左克生物科技发展有限公司
    2025年08月06日询价
    ¥952
    北京博奥森生物技术有限公司
    2025年10月17日询价
    ¥4200.90
    上海阿拉丁生化科技股份有限公司
    2025年07月11日询价
    AM-0902
    ¥915